BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rubio A, Sánchez-Mut JV, García E, Velasquez ZD, Oliver J, Esteller M, Avila J. Epigenetic control of somatostatin and cortistatin expression by β amyloid peptide. J Neurosci Res 2012;90:13-20. [PMID: 21922516 DOI: 10.1002/jnr.22731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Bellver-Sanchis A, Pallàs M, Griñán-Ferré C. The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer's Disease. Epigenomes 2021;5:15. [PMID: 34968302 DOI: 10.3390/epigenomes5020015] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Wang AL, Gruzieva O, Qiu W, Kebede Merid S, Celedón JC, Raby BA, Söderhäll C, DeMeo DL, Weiss ST, Melén E, Tantisira KG. DNA methylation is associated with inhaled corticosteroid response in persistent childhood asthmatics. Clin Exp Allergy 2019;49:1225-34. [PMID: 31187518 DOI: 10.1111/cea.13447] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Winick-Ng W, Rylett RJ. Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer's Disease. Front Mol Neurosci 2018;11:60. [PMID: 29541020 DOI: 10.3389/fnmol.2018.00060] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
4 Broderick PA, Wenning L, Li YS. Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine. J Neural Transm (Vienna) 2017;124:57-78. [PMID: 27796511 DOI: 10.1007/s00702-016-1633-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Saiz-Sanchez D, De la Rosa-Prieto C, Ubeda-Banon I, Martinez-Marcos A. Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer's disease. Brain Struct Funct 2015;220:2011-25. [PMID: 24748561 DOI: 10.1007/s00429-014-0771-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
6 Sanchez-Mut JV, Aso E, Heyn H, Matsuda T, Bock C, Ferrer I, Esteller M. Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease. Hippocampus 2014;24:363-8. [PMID: 24436131 DOI: 10.1002/hipo.22245] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
7 Martel G, Dutar P, Epelbaum J, Viollet C. Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front Endocrinol (Lausanne) 2012;3:154. [PMID: 23230430 DOI: 10.3389/fendo.2012.00154] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]